These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18614923)

  • 1. Adherence to antiretrovirals among US women during and after pregnancy.
    Bardeguez AD; Lindsey JC; Shannon M; Tuomala RE; Cohn SE; Smith E; Stek A; Buschur S; Cotter A; Bettica L; Read JS;
    J Acquir Immune Defic Syndr; 2008 Aug; 48(4):408-17. PubMed ID: 18614923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral adherence during pregnancy and postpartum in Latin America.
    Kreitchmann R; Harris DR; Kakehasi F; Haberer JE; Cahn P; Losso M; Teles E; Pilotto JH; Hofer CB; Read JS;
    AIDS Patient Care STDS; 2012 Aug; 26(8):486-95. PubMed ID: 22663185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term postpartum adherence to antiretroviral drugs among women in Latin America.
    Kreitchmann R; Coelho DF; Kakehasi FM; Hofer CB; Read JS; Losso M; Haberer JE; Siberry GK; Harris DR; Yu Q
    Int J STD AIDS; 2016 Apr; 27(5):377-86. PubMed ID: 25931238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: adherence analysis A5084.
    Cohn SE; Umbleja T; Mrus J; Bardeguez AD; Andersen JW; Chesney MA
    AIDS Patient Care STDS; 2008 Jan; 22(1):29-40. PubMed ID: 18442305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal adherence to antiretroviral drugs for preventing mother-to-child transmission of HIV in Zambia.
    Okawa S; Chirwa M; Ishikawa N; Kapyata H; Msiska CY; Syakantu G; Miyano S; Komada K; Jimba M; Yasuoka J
    BMC Pregnancy Childbirth; 2015 Oct; 15():258. PubMed ID: 26459335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional Cash Transfers to Increase Retention in PMTCT Care, Antiretroviral Adherence, and Postpartum Virological Suppression: A Randomized Controlled Trial.
    Yotebieng M; Thirumurthy H; Moracco KE; Edmonds A; Tabala M; Kawende B; Wenzi LK; Okitolonda EW; Behets F
    J Acquir Immune Defic Syndr; 2016 Aug; 72 Suppl 2(Suppl 2):S124-9. PubMed ID: 27355499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postpartum viral load rebound in HIV-1-infected women treated with highly active antiretroviral therapy: AIDS Clinical Trials Group Protocol A5150.
    Sha BE; Tierney C; Cohn SE; Sun X; Coombs RW; Frenkel LM; Kalams SA; Aweeka FT; Bastow B; Bardeguez A; Kmack A; Stek A;
    HIV Clin Trials; 2011; 12(1):9-23. PubMed ID: 21388937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreases in Self-Reported ART Adherence Predict HIV Viremia Among Pregnant and Postpartum South African Women.
    Phillips TK; Wilson IB; Brittain K; Zerbe A; Mellins CA; Remien RH; Orrell C; Abrams EJ; Myer L
    J Acquir Immune Defic Syndr; 2019 Mar; 80(3):247-254. PubMed ID: 30422906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States.
    Griner R; Williams PL; Read JS; Seage GR; Crain M; Yogev R; Hazra R; Rich K;
    AIDS Patient Care STDS; 2011 Jul; 25(7):385-94. PubMed ID: 21992592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral Prescribing Practices Among Pregnant Women Living With HIV in the United States, 2008-2017.
    Powis KM; Huo Y; Williams PL; Kacanek D; Jao J; Patel K; Seage GR; Van Dyke RB; Chadwick EG;
    JAMA Netw Open; 2019 Dec; 2(12):e1917669. PubMed ID: 31851347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.
    Read JS; Cahn P; Losso M; Pinto J; Joao E; Duarte G; Cardoso E; Freimanis-Hance L; Stoszek SK;
    Obstet Gynecol; 2007 Jun; 109(6):1358-67. PubMed ID: 17540808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Structured Mentor Mother Programs on 6-Month Postpartum Retention and Viral Suppression among HIV-Positive Women in Rural Nigeria: A Prospective Paired Cohort Study.
    Sam-Agudu NA; Ramadhani HO; Isah C; Anaba U; Erekaha S; Fan-Osuala C; Galadanci H; Charurat M
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S173-S181. PubMed ID: 28498187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-Infected Ugandan Women on Antiretroviral Therapy Maintain HIV-1 RNA Suppression Across Periconception, Pregnancy, and Postpartum Periods.
    Matthews LT; Ribaudo HB; Kaida A; Bennett K; Musinguzi N; Siedner MJ; Kabakyenga J; Hunt PW; Martin JN; Boum Y; Haberer JE; Bangsberg DR
    J Acquir Immune Defic Syndr; 2016 Apr; 71(4):399-406. PubMed ID: 26495883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of mother-to-child transmission of HIV: Postpartum adherence to Option B+ until 18 months in Western Uganda.
    Decker S; Rempis E; Schnack A; Braun V; Rubaihayo J; Busingye P; Tumwesigye NM; Harms G; Theuring S
    PLoS One; 2017; 12(6):e0179448. PubMed ID: 28662036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Same-day antiretroviral therapy (ART) initiation in pregnancy is not associated with viral suppression or engagement in care: A cohort study.
    Langwenya N; Phillips TK; Brittain K; Zerbe A; Abrams EJ; Myer L
    J Int AIDS Soc; 2018 Jun; 21(6):e25133. PubMed ID: 29939483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceived Barriers to Antepartum HIV Medication Adherence in HIV Infected Pregnant Women.
    Zahedi-Spung L; Young M; Haddad LB; Badell ML
    Infect Dis Obstet Gynecol; 2018; 2018():4049212. PubMed ID: 30410301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of non-adherence to anti-retroviral therapy, the associated factors and infant outcomes among HIV-positive pregnant women: a prospective cohort study in Lesotho.
    Kadima N; Baldeh T; Thin K; Thabane L; Mbuagbaw L
    Pan Afr Med J; 2018; 30():239. PubMed ID: 30574258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low detectable postpartum viral load is associated with HIV transmission in Malawi's prevention of mother-to-child transmission programme.
    Landes M; van Lettow M; Nkhoma E; Tippett Barr B; Truwah Z; Shouten E; Jahn A; Auld A; Kalua T; van Oosterhout JJ
    J Int AIDS Soc; 2019 Jun; 22(6):e25290. PubMed ID: 31180186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of suboptimal adherence and elevated HIV viral load in pregnant women already on antiretroviral therapy when entering antenatal care in Cape Town, South Africa.
    Brittain K; Remien RH; Mellins CA; Phillips TK; Zerbe A; Abrams EJ; Myer L
    AIDS Care; 2018 Dec; 30(12):1517-1523. PubMed ID: 30047287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.